Objective: Psychosocial research in bipolar disorder (BD) has not yet assessed the relative benefits of a short course of psychoeducation (PE), compared with a longer course of cognitive-behavioural therapy (CBT) containing psychoeducational principles. This pilot study evaluated the efficacy and added benefit of adding a course of CBT to a standard course of brief PE, as maintenance therapy for BD.
A lthough pharmacotherapy remains the mainstay of treatment for BD, a large percentage of patients experience residual affective symptoms and significant impairment in psychosocial functioning leading to suboptimal clinical outcomes. [1] [2] [3] [4] [5] Even though rigorous psychotherapy research in BD has lagged behind research in other disorders such as schizophrenia, over the course of the last decade numerous manualized, reproducible, adjunctive psychosocial interventions have been developed. [6] [7] [8] [9] When compared with usual treatment in randomized controlled trials, these new interventions have been shown to be feasible and efficacious. [10] [11] [12] [13] Although PE, CBT, and FFT are distinct treatments, all share an emphasis on the following: empowering the patient to become an active participant in treatment; becoming more aware of the nature and treatment of BD and the need to adhere to pharmacotherapy treatment; and recognizing the prodromal symptoms of major depression and hypomania to forestall a full-blown relapse. [14] [15] [16] However, still unanswered is how these 3 distinct, active psychosocial treatments compare with each other, and whether these psychotherapeutic interventions have incremental clinical value when added to the treatment of patients with BD who are already adherent to effective moodstabilizing pharmacotherapy. This latter question is critically important. Does labour-intensive psychotherapy, such as CBT, actually have intrinsic potency in BD, above promoting better medication adherence? Few psychotherapy studies in BD have rigorously controlled for medication intensity and no study to date has stringently evaluated the relative efficacy of a psychosocial treatment when medication compliance was already optimal. 17, 18 Another important question to resolve is whether there is a treatment-by-patient interaction effect. It is quite possible that specific subtypes of patients with BD or affective poles of the illness respond preferentially to different active psychosocial treatments. For example, it was recently asserted that PE may be most effective for reducing the risk of manic relapse, whereas a form of interpersonal therapy for BD-interpersonal and social rhythm therapy-may be most effective for treating depressive symptoms without having any significant impact on relapse. 14, 16, 19 Although PE, FFT, and CBT all share similar goals, our clinical experience suggests that CBT and FFT may require more therapist expertise and patient motivation. CBT and FFT are generally more personalized treatments, requiring more therapist flexibility to tailor the treatment to the patient's needs and goals. Although longer PE models focusing on more complex skill acquisition were recently developed and tested, CBT demands that patients adhere to their homework schedule, which may make it less feasible for many BD patients. 15, 16 Due to the chronic nature of BD, the scarcity of psychotherapy within our cost-containment environment and the high likelihood of prematurely terminating psychotherapy treatment, delineating the relative effectiveness of these 3 similar manualized treatments is crucial so that more rational and targeted treatment can be provided to patients with BD.
In the present real-world study, we sought to pragmatically address some of these outstanding questions by conducting a maintenance study comparing 2 adjunctive psychosocial interventions. CBT combined with PE was compared with PE alone. We hypothesized that in BD patients who were in partial or full remission from an index episode, additional sessions of adjunctive CBT added to a standard brief course of PE would yield significantly lower levels of affective symptoms, higher levels of psychosocial functioning, and fewer requirements for AD pharmacotherapy than a standard brief course of PE alone.
Method
Participants were drawn from a sample of 225 outpatients aged between 18 and 60 years, and were recruited from community hospitals and University of Toronto teaching hospitals. Among these, 163 completed an initial phone screen ( Figure 1 ). Approval was obtained from the University of Toronto Research Ethics Board. All participating subjects provided written informed consent.
Participants eligible for inclusion in the study had a diagnosis of BD I or BD II and were not currently in full episode (mania, hypomania, depressive, or mixed). Mood stabilizers were followed naturalistically in this study. To reduce the confounding effect of medication changes on clinical outcome, all participants had to be taking a standard mood stabilizer regimen, have an outpatient prescribing physician, and have no change in their regimen by their prescribing outpatient physician in the last month prior to entry into the study. As well, none of the participants received any additional CBT during the one-year course of the study. All participants had to have a grade 8 education, fluency in English, and the ability to provide informed consent. We excluded those participants with schizoaffective disorder, antisocial personality disorder, severe medical illness, significant cognitive impairment, active suicide ideation in the last month, and alcohol or substance abuse in the last month. Among the 163 participants, 55 did not meet criteria and 29 refused to participate. The remaining 79 participants were randomized into the control group (PE alone; n = 39) or the treatment group (PE and 13 additional sessions of CBT; n = 40). Stratification was performed according to the number of previous affective episodes in the last year with 0 to 1, compared with greater than 1 ( Figure 1 ).
Participants in both groups received 7 sessions of PE, and pharmacotherapy by an outpatient psychiatrist with all patients monitored naturalistically. The PE consisted of 7 weekly audiotaped individual therapy sessions based on the first 5 chapters of the Basco and Rush CBT manual. 6 The objective was to give a succinct overview of BD using an integrated biopsychosocial model of illness, involving a discussion to enhance medication adherence.
In addition to the PE, the treatment group received 13 weekly audiotaped individual CBT sessions. The CBT was based on the Basco and Rush manual 6 plus our own experience treating bipolar depression. 20 The CBT emphasized collaborative goal setting, cognitive restructuring techniques for depression and mania, problem-solving techniques, and methods to enhance interpersonal communication. In addition, participants receiving CBT were taught self-monitoring of symptoms and sleep patterns, behavioural activation strategies for depression, and stimulus control or antiimpulsivity strategies for hypomania.
Participants were evaluated at baseline and at one-month intervals for a year, for a total of 13 assessments. They were assessed by a blinded observer using the SCID, 21 the HDRS, 16, 22 and the CARS-M. 23 All except the SCID were employed at each one-month assessment. The SCID was Relapse was also defined by hospitalization during the first year. To compare the intensity of pharmacotherapy for each patient, we converted each medication dosage to a number from 0 to 3 (Table 1) .
Participants also completed the DAS, 24 the Social Adjustment Scale-Self Report, 25 the Illness Intrusiveness Rating Scale, 26 and the Quality of Life Enjoyment and Satisfaction Questionnaire 27 at baseline and specific intervals ( Figure 2 ).
In addition, we employed the recently validated National Institute of Mental Health Life Chart Method 28 to evaluate daily subsyndromal mood symptoms and medication compliance. This self-report questionnaire uses functional anchors to measure severity of daily mood symptoms. The research assistant made weekly telephone calls to each subject to complete the chart. Medication adherence was also assessed at these interviews by assessing the number of missed doses of mood stabilizer, AD, or antipsychotic medication per month.
Results
The characteristics of the sample at baseline (n = 79) can be seen in Table 2 . Please note that 33 subjects from the original randomized sample did not complete treatment or dropped out before the 12-month follow-up ( Figure 1 ). Data were analyzed using SPSS software (SPSS Inc, Chicago, IL) and comparisons were made between the 26 participants in the treatment group and the 20 participants in the control group who completed the 1-year follow-up. On average, those who dropped out were more severe than those who remained, as shown in slightly elevated HDRS and CARS-M scores at baseline (Table 3) .
Those who dropped out were more likely to have comorbid conditions. Among those who remained, no difference was found between the control and treatment groups on any of the self-report questionnaires, medication dosage intensities, or mean depression or hypomania days per month at baseline.
The vast majority of participants had high compliance with their medication with more than 90% of scheduled doses being taken. Only 2 of 26 patients in the CBT group and 3 of 20 patients in the control group missed more than 10% of their doses in a month. Relapse rates did not differ between the 2 groups. In the CBT group, 6 of 26 participants relapsed, whereas 4 of 20 control participants relapsed.
On average, participants who received CBT had a greater decrease in HDRS scores than the control group from pre-to posttreatment (F 1,44 = 3.87, P = 0.055). The group who received CBT showed greater improvement on the DAS than the group who received PE alone (F 1,43 = 3.67, P = 0.062).
Medication usage differed between the 2 groups. In our sample (n = 46), 61% had some exposure to ADs over the course of the year. Among the 18 (39%) patients who received AD adjustments, 10 were CBT participants and 8 were control participants. However, 8 of the 10 CBT participants actually had their AD dosages lowered, while 6 of the 8 control participants had their AD dosages increased (Fisher's exact test Upon examination of the daily mood ratings, it was found that the CBT group had a 50% decrease in depressed days per month, compared with the PE alone group (Figure 3 ).
Discussion
We predicted that the group receiving CBT in addition to PE would show lower levels of affective symptoms and higher psychosocial functioning than the group receiving PE alone. Given that among the self-report scales, only the DAS differentiated between the 2 groups posttreatment, it is questionable whether there was more of an improvement in psychosocial functioning in the group that received CBT combined with PE. However, this study was a maintenance study and the scores at baseline on many of these scales were quite low to begin with, suggesting relatively good functioning. In fact, when the very lowest DAS scores were removed, the improvement seen in the CBT group, compared with the PE alone group, became significant. This suggests that a lack of significance may be more related to the restricted range of initially low scores than to a lack of an experimental effect.
A similar phenomenon was observed in the pattern of HDRS scores. Because this was a maintenance study that deliberately tried to recruit outpatients with BD who were not in a full episode, participants in both groups had initially low scores at baseline and most participants' scores remained low throughout the year. Despite this, a significant difference was found on the HDRS between the control and treatment groups. Those who received CBT showed an average decrease of 1.75 points, whereas those in the control group showed an increase of 0.61 between pre-and posttreatment. This small difference is of little clinical relevance and most BD patients in the study remained well, complied with their medication, and did not relapse. We must therefore conclude that dramatic benefits between the 2 psychosocial interventions were not observed.
The areas in which the CBT intervention was demonstrated to possess the greatest advantages were in AD usage and daily mood ratings. Quite remarkable was the group difference on AD treatment intensity. Among the participants who had adjustments, 80% in the CBT group had their dosage intensity decreased, compared with 25% in the PE alone group. A second dramatic result was seen in the number of depression days experienced by each group. The CBT reduced the number of BD-depressed days for each month by 50%, compared with PE alone. Given the ubiquity of subsyndromal depression in BD and its potential impact on psychosocial functioning and quality of life, this finding is clinically relevant.
The results of this study are not dissimilar to those observed in the Systematic Treatment Enhancement Program for BD Study, which examined 4 psychosocial interventions for patients with BD. 29 In this study, 3 intensive psychosocial treatments (FFT, interpersonal and social rhythms therapy, and CBT) were all found to be equally more effective in enhancing recovery from bipolar depression than the short-term collaborative care intervention.
One important methodological limitation in the present naturalistic study is the unequal lengths of the psychosocial interventions. Because the treatment group (CBT and PE) received 13 more sessions than the control group (PE), it is not scientifically possible to ascertain whether the benefits observed in the CBT group were specific to the treatment modality, or whether CBT simply provided a nonspecific benefit from longer active treatment. Indeed, unequal treatment lengths are a frequent limitation found within naturalistic studies. For example, in the Systematic Treatment Enhancement Program for BD Study, the intensive psychosocial interventions were administered for a longer period (up to 30 sessions in 9 months) than was the collaborative care intervention (3 sessions in 6 weeks). 29 A naturalistic design was also used in the Sequenced Treatment Alternatives to Relieve Depression Study, where participants received between 16 to 30 additional CBT sessions lasting about 50 minutes each session. 30 As such, while the current naturalistic design does present methodological limitations, naturalistic studies are used more often in mood disorder research. In our study, although the decreased number of depressed days appeared to last beyond the active treatment phase for almost 6 months, future studies should employ equal treatment lengths and a longer follow-up to more precisely delineate CBT's specific effects and its impact on relapse prevention.
Further methodological limitations of our study include the small sample size and the high level of medication adherence in our sample (which is not consistent with other outpatient studies of medication adherence within this particular patient population). In addition, we did not employ CBT manuals previously validated through independent outcome research (for example, Lam's CBT treatment manual 8 and Colom's PE manual). 13 Some of the strengths of our study were: our broad inclusion criteria, our attempt to reduce the confounding effects of medication changes while at the same time trying to ensure that our study's results could be easily generalized to real clinical practice, and our selection of psychosocial interventions that generalize to the real world. We had relatively broad inclusion criteria and also provided treatment to both BD I and BD II patients rather than just BD I patients, which was the BD sample population of Lam's recent study. 12 Our design also credibly generalizes to real world clinical practice as medication was followed naturalistically and we had one treatment arm brief PE that reflected minimal psychological treatment. Our ecologically-valid study design provided us with the opportunity to assess the value of adding 13 sessions of CBT to a course of basic PE received by every BD subject.
In summary, the main finding in our study was that adding CBT reduced the number of days of subsyndromal depression by one-half, compared with a course of brief PE alone. CBT also appeared to be AD-sparing as it was associated with a lower requirement for AD, compared with PE alone. These results are clinically significant given the recent findings that a high percentage of treated patients with BD in tertiary care practice still remain moderately to severely depressed. 31 The results are also consistent with previous studies that have demonstrated that CBT has efficacy in the treatment of BD in general and bipolar depression in particular. 16, 20 If future studies rigorously controlling for treatment length continue to demonstrate that adjunctive CBT reduces subsyndromal depression, and is AD-sparing in BD, clinicians may have an effective option to treat mild-to-moderate bipolar depression that may be safer and more acceptable to patients than pharmacotherapy alone.
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Résumé : La thérapie cognitivo-comportementale est-elle plus efficace que la psychoéducation dans le trouble bipolaire?
Objectif : La recherche psychosociale dans le trouble bipolaire (TB) n'a pas encore évalué les avantages relatifs d'un traitement abrégé de psychoéducation (PE), comparé à un traitement plus long de thérapie cognitivo-comportementale (TCC) contenant des principes psychoéducationnels. Cette étude pilote a évalué l'efficacité et l'avantage supplémentaire d'ajouter un traitement de TCC à un traitement standard de PE abrégé, comme traitement d'entretien du TB.
Méthode : Soixante dix-neuf adultes, hommes et femmes, souffrant de TB et prenant des régimes de médicaments stables, qui étaient en rémission totale ou partielle d'un épisode indice (TB I = 52; TB II = 27), ont été randomisés pour recevoir soit 6 séances de PE individuelle, soit 6 séances de PE suivies de 14 séances individuelles additionnelles de TCC. L'humeur et l'observance de la médication étaient cotées une fois la semaine à l'aide de la Life Chart Method du National Institute of Mental Health, tandis que le fonctionnement psychosocial et l'usage des services de santé mentale étaient évalués une fois par mois.
Résultats : Quarante-six participants ont terminé l'étude au complet. Les participants qui ont reçu la TCC en plus de la PE ont eu 50 % moins de journées d'humeur déprimée sur un an. Les participants qui ont reçu la PE seulement avaient plus d'augmentations d'antidépresseurs que ceux ayant reçu la TCC. Il n'y avait pas de différences entre les groupes en ce qui concerne les taux d'hospitalisation, l'observance des médicaments, le fonctionnement psychosocial ou l'usage des services de santé mentale.
Conclusions :
Les données pilotes de cette étude de monde réel suggèrent que même après que la médication est optimisée, un traitement plus long de TCC adjointe peut offrir certains avantages additionnels à un traitement abrégé de PE pour le traitement d'entretien du TB. Des essais randomisés contrôlés plus vastes avec des traitements d'égale longueur sont indiqués.
